Prevention & lipids

1. J Am Coll Cardiol12 Jan 2026

   Cardiovascular Statistics in the United States, 2026: JACC Stats

   Cohort study

2. JACC Adv12 Jan 2026

   Risk Score Development to Predict Postpartum Cardiovascular Disease Incorporating Pregnancy and Nonpregnancy Factors: A Canada-Wide Study

   Diagnostic or prognostic study

3. Circ Popul Health Outcomes12 Jan 2026

   Thirty-Year Atherosclerotic Cardiovascular Disease Risk Among US Adults Aged 30 to 59 Years

   Cross-sectional study

4. Eur Heart J9 Jan 2026

   Air pollution, meteorological factors, and cardiac remodelling in children: a multi-omics cohort study

   Cohort study

5. Eur J Prev Cardiol8 Jan 2026

   The proteomic profile of leisure time physical activity across two decades: implications for future cardiovascular risk and mortality

   Cohort study

6. Eur Heart J7 Jan 2026

   Cardiovascular adaptation to training load in endurance athletes: a longitudinal study

   Cohort study

7. Eur J Prev Cardiol6 Jan 2026

   Impact of PM2.5 Exposure on Cardiovascular diseases (IPEC Study): an updated umbrella review of systematic reviews and meta-analyses

   Meta-analysis

8. Eur J Prev Cardiol6 Jan 2026

   Risk of suicide in individuals with atherosclerotic cardiovascular disease: a nationwide population-based study

   Cohort study

9. Eur J Prev Cardiol5 Jan 2026

   Gender-affirming hormone therapy and vascular health: walking the line between caution and confidence

   Cohort study

10. JACC Adv2 Jan 2026

    Risk of Cardiovascular Events Using the SMART Polyvascular Disease Risk Score

    Diagnostic or prognostic study

11. Eur J Prev Cardiol17 Dec 2025

    Prenatal particulate air pollution exposure predicts arterial stiffness in childhood

    Cohort study

12. Circulation16 Dec 2025

    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

    Guideline or statement

13. Eur J Prev Cardiol16 Dec 2025

    Prevalence and determinants of adherence to statin therapy: a systematic review and meta-analysis

    Meta-analysis

14. Eur Heart J11 Dec 2025

    C-reactive protein and cardiovascular risk in the general population

    Cohort study

15. Eur J Prev Cardiol11 Dec 2025

    Sex differences in cardiovascular disease risk and the role of biological aging pace

    Cohort study

16. J Am Coll Cardiol10 Dec 2025

    Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER

    Secondary analysis

17. J Am Coll Cardiol9 Dec 2025

    Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos

    Cohort study

18. Eur J Prev Cardiol5 Dec 2025

    Elevated apoB due to high remnant cholesterol confers high risk of ASCVD without prompting sufficient lipid-lowering therapy: a guideline-based limitation and an unmet medical need

    Cohort study

19. JACC Cardiovasc Imaging1 Dec 2025

    Cardiovascular Imaging Considerations for Masters-Aged Athletes

    Research article

20. Eur J Prev Cardiol1 Dec 2025

    A novel cumulative social advantage metric for enhancing the cardiovascular health construct and predicting mortality risk

    Cohort study

21. JAMA Cardiol1 Dec 2025

    Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of Aspirin

    Secondary analysis

22. JAMA Cardiol1 Dec 2025

    Small-Interfering RNA Olpasiran and Apolipoprotein B Particles

    Secondary analysis

23. J Am Coll Cardiol25 Nov 2025

    Age and Sex-Specific Percentiles of 30-Year Cardiovascular Disease Risk Based on the PREVENT Equations

    Cross-sectional study

24. Eur J Prev Cardiol24 Nov 2025

    Association of high-density lipoprotein cholesterol with the top 10 causes of death

    Cohort study

25. Eur J Prev Cardiol24 Nov 2025

    Impact of LDL-C and apolipoprotein B level discordance and associated lipoprotein particle alterations on cardiovascular outcomes in a large primary prevention population

    Cohort study

26. Eur J Prev Cardiol24 Nov 2025

    The contribution of adolescent cardiovascular disease risk factors to vascular stiffness and cardiac remodelling in young adults

    Cohort study

27. Eur J Prev Cardiol19 Nov 2025

    High-sensitivity C-reactive protein and cardiovascular events in a multi-ethnic cohort: the HELIUS study

    Cohort study

28. Eur J Prev Cardiol18 Nov 2025

    Impact of PCSK9 inhibitors on lipoprotein(a) levels: a multi-centre study

    Cohort study

29. Circulation13 Nov 2025

    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association

    Guideline or statement

30. J Am Coll Cardiol10 Nov 2025

    Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk: MESA and UK Biobank

    Cohort study

31. J Am Coll Cardiol10 Nov 2025

    Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System

    Cohort study

32. N Engl J Med8 Nov 2025

    Evolocumab in Patients without a Previous Myocardial Infarction or Stroke

    Randomised controlled trial

33. Eur Heart J4 Nov 2025

    Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study

    Cohort study

34. Circulation3 Nov 2025

    Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke

    Secondary analysis

35. Circulation28 Oct 2025

    Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association

    Guideline or statement

36. Eur J Prev Cardiol27 Oct 2025

    Long-term ambient air pollution exposure and coronary calcium score in men: insights from the DANCAVAS study

    Cross-sectional study

37. Eur Heart J23 Oct 2025

    LDL-cholesterol in newborns and children with genetically verified familial hypercholesterolaemia: implications for cholesterol-based screening

    Cohort study

38. Eur J Prev Cardiol23 Oct 2025

    Relationship of the healthy diet characteristics recommended by the 2021 ESC guidelines with vascular events in patients with established CVD

    Cohort study

39. Eur J Prev Cardiol22 Oct 2025

    Clinical significance of elevated lipoprotein(a) in primary and secondary prevention: a multi-institutional study

    Cohort study

40. BMJ22 Oct 2025

    Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study

    Diagnostic or prognostic study

All 838 Briefs in ExploreShowing Briefs 321–360 of 838, newest first